Hepatitis B serologic survey and review of immunization records of children, adolescents and adults in Fiji, 2008–2009

por Tsukakoshi, Tatsuhiko, Samuela, Josaia, Rafai, Eric V, Rabuatoka, Uraia, Honda, Sumihisa, Kamiya, Yasuhiko, Buerano, Corazon C, Morita, Kouichi
Publicado 2015

Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for...

por Jambulingam, Purushothaman, Subramanian, Swaminathan, Krishnamoorthy, Kaliannagounder, Supali, Taniawati, Fischer, Peter, Dubray, Christine, Fayette, Carl, Lemoine, Jean Frantz, Laman, Moses, King, Christopher, Samuela, Josaia, Hardy, Myra, Weil, Gary J.
Publicado 2022

The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised t...

por Hardy, Myra, Samuela, Josaia, Kama, Mike, Tuicakau, Meciusela, Romani, Lucia, Whitfeld, Margot J., King, Christopher L., Weil, Gary J., Grobler, Anneke C., Robinson, Leanne J., Kaldor, John M., Steer, Andrew C.
Publicado 2020

Community control strategies for scabies: A cluster randomised noninferiority trial

por Hardy, Myra, Samuela, Josaia, Kama, Mike, Tuicakau, Meciusela, Romani, Lucia, Whitfeld, Margot J., King, Christopher L., Weil, Gary J., Schuster, Tibor, Grobler, Anneke C., Engelman, Daniel, Robinson, Leanne J., Kaldor, John M., Steer, Andrew C.
Publicado 2021

Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach

por Goss, Charles W., O’Brian, Katiuscia, Dubray, Christine, Fischer, Peter U., Hardy, Myra, Jambulingam, Purushothaman, King, Christopher L., Laman, Moses, Lemoine, Jean Frantz, Robinson, Leanne J., Samuela, Josaia, Subramanian, Swaminathan, Supali, Taniawati, Weil, Gary J., Schechtman, Kenneth B.
Publicado 2019

The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study

por Weil, Gary J., Bogus, Joshua, Christian, Michael, Dubray, Christine, Djuardi, Yenny, Fischer, Peter U., Goss, Charles W., Hardy, Myra, Jambulingam, Purushothaman, King, Christopher L., Kuttiat, Vijesh Sridhar, Krishnamoorthy, Kaliannagounder, Laman, Moses, Lemoine, Jean Frantz, O’Brian, Katiuscia K., Robinson, Leanne J., Samuela, Josaia, Schechtman, Kenneth B., Sircar, Anita, Srividya, Adinarayanan, Steer, Andrew C., Supali, Taniawati, Subramanian, Swaminathan
Publicado 2019

A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis

por Krentel, Alison, Basker, Nandha, Beau de Rochars, Madsen, Bogus, Joshua, Dilliott, Daniel, Direny, Abdel N., Dubray, Christine, Fischer, Peter U., Ga, Adriani Lomi, Goss, Charles W., Hardy, Myra, Howard, Cade, Jambulingam, Purushothaman, King, Christopher L., Laman, Moses, Lemoine, Jean Frantz, Mallya, Shruti, Robinson, Leanne J., Samuela, Josaia, Schechtman, Ken B., Steer, Andrew C., Supali, Taniawati, Tavul, Livingstone, Weil, Gary J.
Publicado 2021

The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific

por Rainima-Qaniuci, Merelesita, Lepaitai, Hansell Blanche, Bhagirov, Rasul, Padmasiri, Eswara, Naseri, Take, Thomsen, Robert, Won, Kimberly Y., Brant, Tara A., Dodd, Emily, Nua, Motusa Tuileama, Utu, Fara, Tufa, Aifili, Chutaro, Emi, Camacho, Janet, Suiaunoa-Scanlan, Lynette, Thean, Li Jun, Mani, Jyotishna, Hardy, Myra, Samuela, Josaia, Romani, Lucia, Kaldor, John, Steer, Andrew C., Faktaufon, Daniel, Bechu, Vinaisi, Naqio, Flora, Sosene, Vine, Sekihara, Makoto, Otaki, Junko, Buhagiar, Tamara S., Yajima, Aya
Publicado 2022